Zacks Industry Outlook Highlights: American Reprographics,

Administaff, Gevity and Ventiv Health 
CHICAGO--(BUSINESS WIRE)--Nov. 14, 2005
Zacks.com releases its latest Industry Outlook. This
report identifies the best stocks in the top-ranked industries.
Featured in the latest report is the business services industry, with
a focus on the following stocks: American Reprographics Company
(NYSE:ARP), Administaff, Inc. (NYSE:ASF), Gevity (NASDAQ:GVHR) and
Ventiv Health, Inc. (NASDAQ:VTIV). To read the complete Industry
Outlook report and to see all of the top-ranked industries, visit
http://at.zacks.com/?id=2177. 
Here are details on the stocks featured in the latest Industry
Outlook. 
American Reprographics Company (NYSE:ARP) reported a strong third
quarter in late October as momentum continued in all business
segments. The company posted earnings per share of 23 cents that
topped the consensus by almost 10%. Furthermore, revenue advanced
15.7% to $127.5 million from $110.2 million year-over-year. Looking
forward, American Reprographics plans to open new locations and enter
new markets. 
Administaff, Inc. (NYSE:ASF) posted third quarter earnings per
share of 26 cents, marking a strong improvement from last year's 14
cents. The result also eclipsed the consensus by approximately 13%.
Revenues reached $285.2 million, or 20.9% over the same period in
2004. The company said that its unit growth rate has increased ahead
of schedule due to improved sales efficiency, strong client retention
and some contribution from new hires within the existing client base. 
Gevity (NASDAQ:GVHR) (formerly known as Staff Leasing, Inc.) put
together a solid third quarter performance. Earnings per share
advanced 27.6% year-over-year to 37 cents from 29 cents. The result
also bettered the consensus by more than 15%. Revenues grew 3.3% to
$152.9 million from $148 million. For 2005, Gevity expects its full
year 2005 earnings per share guidance of between $1.30 and $1.35,
based on results for the first nine month of 2005 and on anticipated
performance for the remainder of the year. 
Ventiv Health, Inc. (NASDAQ:VTIV) posted third quarter net income
per share from continuing operations of 30 cents, excluding items,
compared to 20 cents in the third quarter of 2004. The result topped
the consensus by 25%. Total revenues advanced 44% to $128.4 million
from $88.9 million year-over-year. The company said its quarter
underscored its strong market positioning and continued effective
execution across all of its businesses. 
About Zacks Industry Outlook 
These stocks featured above have a Zacks Rank of #1 ("Strong Buy")
or #2 ("Buy") and a Zacks Equity Research rating of "Buy". The Zacks
Rank is a quantitative indicator designed to cover periods of 1-3
months. Zacks Equity Research recommendations are based on both
quantitative and qualitative factors and are intended to cover periods
of 3-6 quarters. 
For over 18 years, the Zacks Rank has proven that "Earnings
estimate revisions are the most powerful force impacting stock
prices." Since inception in 1988, #1 Rank stocks have generated an
average annual return of +33%. During the 2000-2002 bear market, Zacks
#1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also
note that the Zacks Rank system has just as many Strong Sell
recommendations (Rank #5) as Strong Buy recommendations (Rank #1).
Since 1988, Zacks Rank #5 stocks have underperformed the S&P 500 by
143.5% annually (+4.9% vs. +12%). Thus, the Zacks Rank system allows
investors to truly manage portfolio trading effectively. 
Zacks "Profit from the Pros" e-mail newsletter offers continuous
coverage of the industries and the stocks poised to outperform the
market. Subscribe to this free newsletter today by visiting
http://at.zacks.com/?id=2177. 
The Zacks Rank, and all of its recommendations, is created by
Zacks & Co., member NASD. Zacks.com displays the Zacks Rank with
permission from Zacks & Co. on its web site for individual investors. 
About Zacks 
Zacks.com is a property of Zacks Investment Research, Inc., which
was formed in 1978 to compile, analyze, and distribute investment
research to both institutional and individual investors. The guiding
principle behind Zacks work is the belief that investment experts,
such as brokerage analysts and investment newsletter writers, have
superior knowledge about how to invest successfully. The goal is to
unlock these pros' profitable insights for individual investors
hard-pressed to find this valuable information in one source. A free
subscription to "Profit from the Pros" weekly e-mail newsletter
provides the best way to use these experts' insights for more
profitable investing. Register for a free subscription to Profit from
the Pros by going to http://at.zacks.com/?id=2177 
Zacks Investment Research is under common control with affiliated
entities (including a broker-dealer and an investment adviser), which
may engage in transactions involving the foregoing securities for the
clients of such affiliates. 
(a) The Zacks Performance Rank performance is the total return of
equal weighted simulated portfolios consisting of those stocks with
the indicated Zacks Rank net of fees. Results reflect the reinvestment
of dividends and other earnings. Simulated results do not represent
actual trading and may not reflect the impact that economic and market
factors might have had on decision-making if an adviser were actually
managing a client's money. 
(b) The S&P 500 Index ("S&P 500") is a well-known, unmanaged index
of the prices of 500 large-company common stocks selected by Standard
& Poor's. The S&P 500 includes the reinvestment of all dividends, no
transaction costs, and represents the gross returns before management
fees. 
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an offer
or solicitation to buy or sell any security. 
CONTACT:
Zacks.com
Jim Giaquinto, 312-630-9880 x 268
pr@zacks.com
www.Zacks.com
 
 
Press spacebar to pause and continue. Press esc to stop.